Cargando…

Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone

Background Male hypogonadism has a prevalence of about 6% and is defined by two-morning testosterone levels below 300 ng/dl associated with symptoms. This definition presents a challenging problem for patients without other medical problems but with symptoms of low testosterone (T) who do not meet t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zucker, Isaac, Rainer, Quinn, Pai, Raghav K, Ramasamy, Ranjith, Masterson, Thomas A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Urology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246432/ https://www.ncbi.nlm.nih.gov/pubmed/35800844 http://dx.doi.org/10.7759/cureus.25543

Ejemplares similares

The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use
por: Rainer, Quinn, et al.
Publicado: (2022)

Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL
por: Madhusoodanan, Vinayak, et al.
Publicado: (2019)

Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
por: Delgado, Jessica, et al.
Publicado: (2022)

Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
por: Lee, John Alden, et al.
Publicado: (2018)

Testosterone versus clomiphene citrate in managing symptoms of hypogonadism in men
por: Dadhich, Pranav, et al.
Publicado: (2017)

Serum testosterone levels in male hypogonadism: Why and when to check—A review
por: Livingston, Mark, et al.
Publicado: (2017)

Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism
por: Çelik, Mehmet, et al.
Publicado: (2021)

The Interest in Permanent Contraception Peaked Following the Leaked Supreme Court Majority Opinion of Roe vs. Wade: A Cross-Sectional Google Trends Analysis
por: Ghomeshi, Armin, et al.
Publicado: (2022)

Human chorionic gonadotropin therapy in hypogonadic severe-oligozoospermic men and its effect on semen parameters
por: Andrabi, Syed Waseem, et al.
Publicado: (2022)

U-shaped Association Between Prevalence of Secondary Hypogonadism and Body Mass Index: A Retrospective Analysis of Men with Testosterone Deficiency
por: Gurayah, Aaron A., et al.
Publicado: (2023)

Voiding function improves under long-term testosterone treatment (TTh) in hypogonadal men, independent of prostate size
por: Yassin, Aksam, et al.
Publicado: (2023)

Testosterone undecanoate supplementation together with human chorionic gonadotropin does not impair spermatogenesis in males with isolated hypogonadotropic hypogonadism: a retrospective study
por: Chen, Yin-Wei, et al.
Publicado: (2019)

Factors Associated With Restarting Androgenic Anabolic Steroids After Cessation in Men With Infertility: A Retrospective Analysis
por: White, Josh, et al.
Publicado: (2023)

Do Women Have a Seat at the Table: Trends in Female Representation Among the Board of Directors in American Urological Association Subspecialty Societies
por: Dullea, Alexandra D, et al.
Publicado: (2022)

Hypogonadism induced by surgical stress and brain trauma is reversed by human chorionic gonadotropin in male rats: A potential therapy for surgical and TBI‐induced hypogonadism?
por: Geddes, Rastafa I., et al.
Publicado: (2021)

A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men
por: Swerdloff, Ronald S, et al.
Publicado: (2020)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Psychometric testing of two new patient‐reported outcome instruments for the evaluation of treatment for hypogonadism
por: Hayes, R. P., et al.
Publicado: (2016)

Corrigendum for: “A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men”
Publicado: (2020)

Penile Growth in Response to Human Chorionic Gonadotropin (hCG) Treatment in Patients with Idiopathic Hypogonadotrophic Hypogonadism
por: Kim, Sun-Ouck, et al.
Publicado: (2011)

Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021)

The Effects of Fetal Gender on Serum Human Chorionic Gonadotropin and Testosterone in Normotensive and Preeclamptic Pregnancies
por: Lorzadeh, Nahid, et al.
Publicado: (2012)

Elevated Body Mass Index Is Associated with Secondary Hypogonadism among Men Presenting to a Tertiary Academic Medical Center
por: Masterson, John M., et al.
Publicado: (2019)

Alpha-foetoprotein and human chorionic gonadotropin in men with maldescended testes.
por: von Eyben, F., et al.
Publicado: (1980)

Evaluating the Combination of Human Chorionic Gonadotropin and Clomiphene Citrate in Treatment of Male Hypogonadotropic Hypogonadism: A Prospective Study
por: Trinh, The Son, et al.
Publicado: (2021)

Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials
por: Diaz, Parris, et al.
Publicado: (2023)

d-Chiro-Inositol improves testosterone levels in older hypogonadal men with low-normal testosterone: a pilot study
por: Nordio, Maurizio, et al.
Publicado: (2021)

Retracted: The Effects of Fetal Gender on Serum Human Chorionic Gonadotropin and Testosterone in Normotensive and Preeclamptic Pregnancies
por: Journal of Pregnancy,
Publicado: (2013)

Preoperative Testosterone Therapy Prior to Surgical Correction of Hypospadias: A Review of the Literature
por: Krishnan, Arvind, et al.
Publicado: (2016)

Risks of testosterone replacement therapy in men
por: Osterberg, E. Charles, et al.
Publicado: (2014)

The Impact of Ovulation Calculators on the Stress Levels of Fertility-Seeking Couples: An Evaluation Study
por: Ledesma, Braian R, et al.
Publicado: (2023)

Low free testosterone is associated with hypogonadal signs and symptoms in men with normal total testosterone levels: results from the European Male Ageing Study
por: Antonio, Leen, et al.
Publicado: (2015)

Treatment situation of male hypogonadotropic hypogonadism in pediatrics and proposal of testosterone and gonadotropins replacement therapy protocols
por: Sato, Naoko, et al.
Publicado: (2015)

The Efficiency and Safety of Mirabegron Monotherapy for the Treatment of Urge Incontinence in Women Aged >80 Years
por: Özcan, Cihat, et al.
Publicado: (2023)

A Case Report on “Pearling”: Removal of Infected Objects During Circumcision
por: Xu, Raymond, et al.
Publicado: (2023)

Transcriptional Differences in Identical Twins With Different Reproductive Capacities: A Case Report
por: Campbell, Katherine, et al.
Publicado: (2023)

Serum testosterone and gonadotropins levels in patients with premature ejaculation: A comparison with normal men
por: Mohseni, Mohammad G., et al.
Publicado: (2014)

ChatGPT's Ability to Assess Quality and Readability of Online Medical Information: Evidence From a Cross-Sectional Study
por: Golan, Roei, et al.
Publicado: (2023)

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
por: Kunath, Frank, et al.
Publicado: (2015)

A Case of Suspected Isolated Follicle-Stimulating Hormone (FSH) Deficiency Where Spermatogenesis Was Acquired by Human Menopausal Gonadotropin (hMG)
por: Sugie, Miho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kb7s4gnuhub5htspv09mskopcq